Rare diseases
Investigational molecules
Locations
Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis
PolandStudy on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
PolandStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
PolandStudy of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis
PolandStudy on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A
PolandLong-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency
PolandStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
PolandLong-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease
PolandStudy on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care
PolandStudy on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies
PolandEfficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
PolandContinued Cancer Treatment Study with Abiraterone, Ipatasertib, Tiragolumab, and Drug Combination for Patients from Previous Genentech/Roche Trials
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
